Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Tenorio-Torres

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|April 15, 2021
Comprehensive omic characterization of breast cancer in Mexican-Hispanic womenSandra L Romero-Cordoba, Ivan Salido-Guadarrama, Rosa Rebollar-Vega, et al.
Frontiers in Oncology|November 16, 2020
Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in TumorsCarlos Jhovani Pérez-Amado, Hugo Tovar, Laura Gómez-Romero, et al.
Scientific Reports|August 6, 2020
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtypeAlberto Cedro-Tanda, Magdalena Ríos-Romero, Sandra Romero-Córdoba, et al.
Clinical Breast Cancer|May 24, 2024
Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated FactorsFernanda Mesa-Chavez, Yanin Chavarri-Guerra, Adara Valeria López-Covarrubias, et al.
Scientific Reports|August 26, 2020
FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patientsMagdalena Ríos-Romero, Alberto Cedro-Tanda, Mónica Peña-Luna, et al.
Molecular Oncology|January 17, 2019
Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell deathFredy Omar Beltrán-Anaya, Sandra Romero-Córdoba, Rosa Rebollar-Vega, et al.
Frontiers in Oncology|April 29, 2021
LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related GenesMireya Cisneros-Villanueva, Lizbett Hidalgo-Pérez, Alberto Cedro-Tanda, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|April 15, 2021
Comprehensive omic characterization of breast cancer in Mexican-Hispanic womenSandra L Romero-Cordoba, Ivan Salido-Guadarrama, Rosa Rebollar-Vega, et al.
Frontiers in Oncology|November 16, 2020
Mitochondrial DNA Mutation Analysis in Breast Cancer: Shifting From Germline Heteroplasmy Toward Homoplasmy in TumorsCarlos Jhovani Pérez-Amado, Hugo Tovar, Laura Gómez-Romero, et al.
Scientific Reports|August 6, 2020
A lncRNA landscape in breast cancer reveals a potential role for AC009283.1 in proliferation and apoptosis in HER2-enriched subtypeAlberto Cedro-Tanda, Magdalena Ríos-Romero, Sandra Romero-Córdoba, et al.
Clinical Breast Cancer|May 24, 2024
Multicenter Study on the Frequency of Low Bone Mineral Density in Young Women With Breast Cancer and Associated FactorsFernanda Mesa-Chavez, Yanin Chavarri-Guerra, Adara Valeria López-Covarrubias, et al.
Scientific Reports|August 26, 2020
FAM83H-AS1 is a potential modulator of cancer driver genes across different tumors and a prognostic marker for ER/PR + BRCA patientsMagdalena Ríos-Romero, Alberto Cedro-Tanda, Mónica Peña-Luna, et al.
Molecular Oncology|January 17, 2019
Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell deathFredy Omar Beltrán-Anaya, Sandra Romero-Córdoba, Rosa Rebollar-Vega, et al.
Frontiers in Oncology|April 29, 2021
LINC00460 Is a Dual Biomarker That Acts as a Predictor for Increased Prognosis in Basal-Like Breast Cancer and Potentially Regulates Immunogenic and Differentiation-Related GenesMireya Cisneros-Villanueva, Lizbett Hidalgo-Pérez, Alberto Cedro-Tanda, et al.
Pageof 2